Latest Breaking News On - Immunomodulation treatment - Page 1 : comparemela.com

Nuwellis Distribution Partner, SeaStar Medical, Receives

MINNEAPOLIS, Feb. 22, 2024 (GLOBE NEWSWIRE) Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people.

Dunia cristanAquadex smartflowNestor jaramillo jrEric schlorffVivian cervantesOffice of orphan products developmentSeastar medical holding corporation nasdaqNuwellis incDrug administrationSeastar medical holding corporationGilmartin groupStar medical holding corporationSeastar medicalHumanitarian device exemptionSelective cytophereticNestor jaramillo

SeaStar Medical and Nuwellis Enter into a U S License and Distribution Agreement for SeaStar Medical s Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI)

SeaStar Medical and Nuwellis Enter into a U S License and Distribution Agreement for SeaStar Medical s Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJody cainPatty caballeroEric schlorffAquadex smartflowNestor jaramillo jrKidney internationalDrug administrationNuwellis incSeastar medical holding corporationseastarAnnika parrish healthSeastar medical holding corporation nasdaqNuwellisnuwellis incGilmartin group vivian cervantesStar medical holding corporationSeastar medical

SeaStar Medical and Nuwellis Enter into a U S License and

Approximately 4,000 children in the U.S. with AKI require Continuous Kidney Replacement Therapy (CKRT).

United statesEric schlorffAquadex smartflowNestor jaramillo jrSeastar medical holding corporationKidney internationalDrug administrationNuwellis incSeastar medical holding corporation nasdaqStar medical holding corporationSeastar medicalSelective cytopheretic deviceStar medicalHumanitarian device exemptionChief executive officerNestor jaramillo